• About
  • Subscribe
  • Advertise
  • Contact
Saturday, December 6, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

All-new Alcon Unity vitreoretinal and cataract systems approved in Australia

by Myles Hume
December 4, 2024
in Cataract, Company updates & acquisitions, Eye disease, Local, Macular disease - AMD, News, Ophthalmic equipment & diagnostics, Ophthalmic insights, Policy & regulation, TGA
Reading Time: 4 mins read
A A
Alcon has announced its latest financial results. Image: Konektus Photo/Shutterstock.com.

Alcon has announced its latest financial results. Image: Konektus Photo/Shutterstock.com.

Share on FacebookShare on Twitter

Alcon has revealed its “highly anticipated” Unity Vitreoretinal Cataract System [VCS] and Unity Cataract System [CS] have been included on the Australian Register of Therapeutic Goods and notified to the WAND database in New Zealand.

These innovations are the first to be introduced from the company’s all-new Unity portfolio, and were shown to selected surgeons at the RANZCO Congress in Adelaide in early November 2024.

Unity VCS and Unity CS are designed to deliver enhanced workflow efficiencies over Alcon’s current systems, Constellation Vision System for vitreoretinal and combined procedures, and Centurion Vision System with Active Sentry for cataract surgery.

Unity VCS is described as Alcon’s most advanced vitreoretinal and cataract surgical innovation, combined in one integrated platform Image: Alcon.

Unity VCS is described as Alcon’s “most advanced vitreoretinal and cataract surgical innovations” combined in one integrated platform. The system provides surgeons and technicians the benefits of maximised operating room space within one device, the company said.

It also includes optional laser indicated for photocoagulation, iridotomy and trabeculoplasty procedures.

Meanwhile, Unity CS is a standalone cataract system for phaco and cataract removal.

According to Alcon, Unity VCS and Unity CS leverage a novel phacoemulsification modality to deliver up to two times faster nucleus removal^ with 40% less energy* into the eye.1

For vitreoretinal surgeons, the new technology offers cutting speeds of up to 30,000 cuts per minute.#2 The platform offers surgical stability and efficiency with “a unique proprietary fluidics system”.3

More details on these and innovations to its instrumentation and consumables will be available at launch some time in 2025.

Alcon has tested Unity VCS and Unity CS during investigational advisory wet lab sessions with more than 200 highly experienced surgeons from 30+ countries, including several Australian ophthalmologists.

“At Alcon, we have a long legacy of involving our customers throughout the research and development process to deliver bold innovation in ophthalmology, and we would like to thank those who helped us arrive at [this] milestone,” said Mr Franck Leveiller, Alcon’s head of global R&D and chief scientific officer.

“We are excited to introduce the next-generation of equipment solutions and consumables – in cataract and vitreoretinal surgery – and deliver meaningful impact for eyecare professionals and patients.”

Worldwide, there will be an estimated 31 million cataract surgeries in 2024, and that number is expected to increase to 37 million by 2029.4 There will be approximately 2.2 million vitrectomy procedures in 2024 across the globe.5

Alcon said it recognised that the increasing demand necessitates enhanced workflow efficiencies and improved patient outcomes.

“We are excited to announce that our latest breakthrough technologies, Unity VCS and Unity CS, have received regulatory approval in Australia and New Zealand,” said Ms Penny Stewart, Alcon ANZ’s cluster franchise head of surgical and country manager.

“Unity VCS and Unity CS build on Alcon’s expertise in surgical equipment with pioneering innovations for vitreoretinal and cataract surgery – driving advancements from cutting speeds to fluidics management, to ergonomics and workflow. We are looking forward to continuing to gather real-world user experiences before we introduce these technologies in 2025.”

Unity VCS and Unity CS are the latest innovations from the Alcon Vision Suite – a product portfolio designed to help eyecare professionals increase clinic and operating room efficiency, and deliver exceptional patient experiences.

“The Alcon Vision Suite will continue to grow with cutting-edge Unity products that are expected to be introduced over the coming years, adding to our market-leading legacy products, which will continue to be available and serviceable,” Alcon stated.

More reading

Alcon supporting optometry students through educational grant

Alcon heralds IOL and contact lens sales in Q2 2024 results

Alcon launches TOTAL30 monthly replacement contact lenses in Australia

References

^ 2x faster nucleus removal than OZIL Torsional phaco
* Based on N=10 HPs, Artificial cataract lens IOP 55mmhg vacuum of 450 mmHg
#Compared to Constellation HYPERVIT 20k vitrectomy probe

  1. Alcon Data on File, 2024 – REF-24379.
  2. REF- 24644.
  3. Unity VCS and CS User Manual 2024 – REF -24980.
  4. Market Scope 2024 IOL Market Report, 2024.
  5. Market Scope 2024 Retinal Surgical Device Market Report, 2024.
  6. Market Scope 2024 Cataract Surgical Equipment Market Report, 2024.

Related Posts

Macular disease consumes 12% of age pension payments, MDFA says. Images: dragonstock/stock.adobe.com & Robyn Mackenzie/Shutterstock.com.

Government flags major shift in PHI claiming for intravitreal injections

by Staff Writer
December 5, 2025

Eyecare practitioners are being advised to prepare for potential disruption to patient billing pathways, with the federal government considering changes...

The ASO believes expanding the medications optometrists can prescribe could put Australians at risk. Image: Johnstocker/stock.adobe.com.

‘We are not seeking to become doctors’ – OA responds to ASO concerns on prescribing

by Rob Mitchell
December 4, 2025

Optometry Australia (OA) says optometrists are “not seeking to become doctors” through proposed changes to rules governing the medicines they...

Associate Professor Raymond Wong (left) and Associate Professor Mohit Shivdasani have each received research funding. Image: Retina Australia

Pioneering sight-restoration projects secure Retina Australia funding

by Staff Writer
December 4, 2025

Retina Australia has announced the recipients of its 2026 research grants, funding two projects that aim to advance potential new...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited